Educational · Plant Science

Mitragyna speciosa: Botany, Traditional Use, and Alkaloid Chemistry

An educational overview of the tropical plant at the origin of kratom alkaloid science, its biology, its historical context, and the chemical compounds it contains.

6-minute readUpdated May 2026

Mitragyna speciosa is a tropical tree native to the rainforests of Southeast Asia, with a documented history of traditional use stretching back generations. In recent decades, the plant's alkaloid compounds have attracted growing scientific attention, not as a consumer product, but as a subject of pharmacological research into opioid receptor biology.

This article provides an educational overview of the plant itself: its botany, its traditional context, and the alkaloids it contains. It is intended as background reading for anyone interested in understanding the scientific and botanical foundations of kratom alkaloid research.

Botanical Classification and Distribution

Mitragyna speciosa belongs to the family Rubiaceae, the same family as coffee (Coffea arabica). It is a large tree capable of reaching heights of 25 metres in its native habitat, with broad, glossy, dark green leaves that are the primary source of its biologically active compounds.

The plant grows natively across several countries in Southeast Asia, including Thailand, Malaysia, Indonesia, and Papua New Guinea. It thrives in humid tropical climates with high rainfall, fertile soils, and proximity to waterways. It is known regionally by various vernacular names: kratom in Thailand, biak in Malaysia, and ketum more broadly across the region.

Historical and Traditional Context

The leaves of Mitragyna speciosa have a well-documented history of use in indigenous communities across its native range, particularly in Thailand and Malaysia. Traditionally, fresh leaves were chewed or brewed into a tea. Historical accounts describe use primarily among agricultural labourers seeking to manage fatigue during extended physical work.

The plant also appears in traditional medicine practices in some regions, though the scope and nature of these uses varied considerably by locality. It is important to note that traditional use patterns differ significantly from the concentrated, standardised alkaloid preparations that are the subject of contemporary pharmacological research.

The legal status of kratom and its derived products has changed considerably in recent decades. In Thailand, kratom was scheduled under narcotics law in 1943 and remained controlled for many decades before being decriminalised for certain uses in 2021. Regulatory status continues to vary significantly between and within countries.

The Alkaloid Profile of Kratom Leaves

The leaves of Mitragyna speciosa contain over 40 identified alkaloids. These are nitrogen-containing organic compounds, many of which interact with receptors in the human nervous system. The composition and concentration of these alkaloids varies considerably across different cultivars, growing regions, seasons, and post-harvest handling methods.

The alkaloids that have received the most scientific characterisation are:

Mitragynine

Mitragynine is the most abundant alkaloid in kratom leaves, typically comprising between 12% and 66% of total alkaloid content depending on the sample. It is a monoterpenoid indole alkaloid and is the principal compound studied in kratom pharmacology research. It acts at opioid receptors, among other targets, and is the chemical precursor from which 7-hydroxymitragynine is derived.

7-Hydroxymitragynine

7-Hydroxymitragynine is present in natural kratom leaves only in trace quantities, typically less than 0.01% in fresh leaves and up to approximately 2% in some processed extracts. It is an oxidised derivative of mitragynine and has been the subject of substantial opioid receptor research due to its high binding affinity at mu-opioid receptors. Because it occurs in such small natural quantities, concentrated 7-OH preparations are produced through semi-synthetic oxidation of extracted mitragynine.

Speciogynine

Typically the second most abundant alkaloid after mitragynine, speciogynine is present at concentrations ranging from approximately 0.1% to 5.3% of leaf dry weight. Research has found it has serotonergic and adrenergic receptor binding activity rather than primary opioid receptor activity. Its specific pharmacological role in the context of the full alkaloid mixture is not fully characterised.

Paynantheine

Present at concentrations of approximately 0.3% to 12.8% of leaf dry weight, paynantheine is one of the more abundant minor alkaloids. Research has found serotonergic and adrenergic activity. Some studies have examined possible smooth muscle effects, though the evidence base is limited.

Speciociliatine

Present at concentrations of approximately 0.4% to 12.3% of leaf dry weight. Speciociliatine has been studied for interaction with opioid receptors and adrenergic receptors. It is considered to have lower opioid receptor activity than mitragynine.

Corynantheidine

A minor alkaloid present at approximately 0.1% to 1.2% of leaf dry weight. Pharmacological research has identified opioid receptor interaction. Its contribution to the overall alkaloid profile at these concentrations is considered minor.

Mitraphylline

Mitraphylline differs from the other alkaloids listed here in that research suggests it may act as a competitive antagonist at mu-opioid receptors, the opposite of agonist activity. This characteristic has made it of interest to researchers studying the composite pharmacology of whole-leaf kratom preparations. Mitraphylline is also found in Uncaria tomentosa (cat's claw) and other plants.

Variability in Alkaloid Content

One of the most practically significant aspects of Mitragyna speciosa chemistry is the substantial variability of alkaloid content across samples. Studies of commercial kratom products have found mitragynine concentrations ranging from approximately 1.2% to 38.7% on a leaf dry weight basis across different products, a variation of more than 30-fold.

This variability is driven by multiple factors: cultivar genetics, growing location, season of harvest, age of the leaves at harvest, and the drying and processing methods applied after collection. Scientific research has demonstrated, for example, that certain post-harvest treatments such as withering can significantly alter alkaloid concentrations relative to fresh leaf material.

This variability is relevant context for understanding why scientific studies must carefully characterise the material they use, and why comparisons between studies using different source materials require caution.